Advertisement
Canadian Journal of Cardiology

Refining the stratification and prognosis of cardiogenic shock patients to improve their outcome

Published:September 05, 2022DOI:https://doi.org/10.1016/j.cjca.2022.09.001

      Summary

      Risk stratification in patients with cardiogenic shock must incorporate the etiology, clinical phenotype, severity, complications, response to therapy, and non-modifiable risk factors for mortality. Tailoring the degree of hemodynamic support to the shock severity is a logical approach, but this must be guided by an in-depth understanding of the patient’s underlying hemodynamics, physiology, and candidacy for advanced therapies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • van Diepen S.
        • Katz J.N.
        • Albert N.M.
        • et al.
        Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.
        Circulation. 2017; 136: e232-e268
      1. Jentzer JC, Rayfield C, Soussi S et al. Advances in the Staging and Phenotyping of Cardiogenic Shock Part 1: Clinical Context JACC: Advances 2022.

        • Jentzer J.C.
        • Rossello X.
        Past, present, and future of mortality risk scores in the contemporary cardiac intensive care unit.
        Eur Heart J Acute Cardiovasc Care. 2021; 10: 940-946
      2. Naidu SS, Baran DA, Jentzer JC et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol 2022.

        • Henry T.D.
        • Tomey M.I.
        • Tamis-Holland J.E.
        • et al.
        Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association.
        Circulation. 2021; 143: e815-e829